Is Yatharth Hospit. overvalued or undervalued?
As of September 4, 2025, Yatharth Hospital is considered very expensive with a high PE ratio of 52.44 and an EV to EBITDA ratio of 30.09, indicating overvaluation despite outperforming the Sensex with a year-to-date return of 36.93%.
As of 4 September 2025, Yatharth Hospital's valuation grade has moved from expensive to very expensive, indicating a significant increase in perceived valuation. The company is currently overvalued, as evidenced by its high PE ratio of 52.44, an EV to EBITDA ratio of 30.09, and a Price to Book Value of 4.64. These metrics suggest that the stock is trading at a premium compared to its earnings and book value.In comparison to its peers, Yatharth Hospital's PE ratio of 52.44 is lower than Max Healthcare's striking 93.55 but higher than Apollo Hospitals' 72.11, which is currently rated as fair. Additionally, Yatharth's EV to EBITDA ratio of 30.09 is more favorable than Fortis Healthcare's 42.53, yet still reflects a very expensive valuation. Notably, Yatharth Hospital has outperformed the Sensex in recent periods, with a year-to-date return of 36.93% compared to the Sensex's 3.30%, reinforcing the notion of its overvaluation amidst strong market performance.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
